These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18928945

  • 1. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE, Melbourne Interventional Group.
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [Abstract] [Full Text] [Related]

  • 2. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):763-8. PubMed ID: 19309731
    [Abstract] [Full Text] [Related]

  • 3. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):874-80. PubMed ID: 19180665
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.
    Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):928-36. PubMed ID: 18044763
    [Abstract] [Full Text] [Related]

  • 5. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ, Melbourne Interventional Group Investigators.
    Int J Cardiol; 2008 Nov 28; 130(3):374-9. PubMed ID: 18706719
    [Abstract] [Full Text] [Related]

  • 6. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, Lv AK, Zhang JS, Shen WF.
    Int J Cardiol; 2009 Jul 24; 136(1):72-9. PubMed ID: 18653250
    [Abstract] [Full Text] [Related]

  • 7. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G, Ramondo A, Napodano M, Favaretto E, Gardin A, Bilato C, Nesseris G, Tarzia V, Cademartiri F, Gerosa G, Iliceto S.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):50-8. PubMed ID: 19089938
    [Abstract] [Full Text] [Related]

  • 8. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 9. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb 01; 14(1):135-40. PubMed ID: 17301639
    [Abstract] [Full Text] [Related]

  • 10. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q, Zhang RY, Shen J, Zhang JS, Hu J, Yang ZK, Zhang X, Zheng AF, Shen WF.
    Chin Med J (Engl); 2008 Dec 05; 121(23):2379-83. PubMed ID: 19102952
    [Abstract] [Full Text] [Related]

  • 11. Age-based differences of percutaneous coronary intervention in the drug-eluting stent era.
    Floyd KC, Jayne JE, Kaplan AV, Friedman BJ, Niles NW, Hettleman BD, Robb JF, Thompson CA.
    J Interv Cardiol; 2006 Oct 05; 19(5):381-7. PubMed ID: 17020561
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators.
    Circulation; 2008 Aug 05; 118(6):632-8. PubMed ID: 18645057
    [Abstract] [Full Text] [Related]

  • 13. Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting.
    Lee MS, Canan T, Perlowski A, Bhatia R, Jurewitz D, Tobis JM.
    J Invasive Cardiol; 2009 Sep 05; 21(9):441-5. PubMed ID: 19726814
    [Abstract] [Full Text] [Related]

  • 14. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, Hayashi K, Ishiki R, Takeichi Y, Iwase M, Inagaki H, Murohara T.
    Am Heart J; 2009 Jul 05; 158(1):92-8. PubMed ID: 19540397
    [Abstract] [Full Text] [Related]

  • 15. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention.
    Blackman DJ, Pinto R, Ross JR, Seidelin PH, Ing D, Jackevicius C, Mackie K, Chan C, Dzavik V.
    Am Heart J; 2006 Jan 05; 151(1):146-52. PubMed ID: 16368308
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L, De Labriolle A, Lemesle G, Steinberg DH, Roy P, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):866-70. PubMed ID: 19198009
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.
    Coron Artery Dis; 2010 Aug 01; 21(5):261-5. PubMed ID: 20555264
    [Abstract] [Full Text] [Related]

  • 18. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW, DELFT (Drug Eluting stent for LeFT main) Registry.
    J Am Coll Cardiol; 2008 Jun 10; 51(23):2212-9. PubMed ID: 18534266
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
    Rothman MT, Jain AK, E-Five Registry Investigators.
    Catheter Cardiovasc Interv; 2012 Nov 15; 80(6):885-92. PubMed ID: 22517785
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.